NVOX Launches US Clinical Network to Address Clinician Time Bottleneck in ADHD Assessment
- Company invites qualified clinicians to join the NVOX Network, its US clinical network, at no cost
- Multimodal platform is designed to reduce clinician workload and make comprehensive ADHD assessment easier to integrate into clinical practice
- NVOX Network launch follows more than three and a half years of development and more than 1,000 completed assessments during NVOX’s initial operating phase
NEWARK, Del., Aug. 24, 2026 /PRNewswire/ — NVOX today announced the launch of the NVOX Network, its US clinical network, and is inviting psychologists, psychiatrists and other qualified clinical professionals to join. The clinician-integrated, multimodal platform is designed to reduce the operational burden surrounding comprehensive ADHD assessment while keeping clinical interpretation in professional hands and final report release subject to licensed clinical review and authorization.
The US launch follows more than three and a half years of development and more than 1,000 completed assessments during NVOX’s initial operating phase. Most recently, NVOX previewed the platform with clinicians and other professionals at APA 2026 in Washington, D.C., gathering feedback ahead of the NVOX Network rollout.
Comprehensive ADHD assessment requires substantial clinician time to gather and reconcile clinical history, developmental and functional information, records, and input from multiple sources while considering alternative explanations for symptoms. A 2026 study led by CDC researchers and published in the Journal of the American Board of Family Medicine found that fewer than half of surveyed clinicians reported offering ADHD diagnostic services in their practices, 46% for adults and 42.6% for children. Among clinicians involved in ADHD care, lack of time to evaluate the patient was the most frequently reported barrier to ADHD identification or diagnosis, cited by roughly four in ten clinicians for both adults and children.
NVOX was built to address that bottleneck.
“Responsible ADHD assessment requires much more than identifying symptoms,” said Johnathan Leemor, M.D., chief science officer at NVOX. “It requires developmental history, functioning, context, information from multiple sources and careful clinical interpretation. NVOX was designed to organize that complexity so clinicians can spend more time understanding the person and applying clinical judgment, and less time assembling the process. Reducing that burden can help expand clinical capacity and access. Professional ADHD assessment should not be a luxury product.”
By reducing the operational work surrounding each case, NVOX is designed to support clinicians through two options:
- NVOX Network: Qualified clinicians who already conduct ADHD assessments or who wish to integrate ADHD assessments into their practice can join the NVOX Network at no cost to use NVOX with their own clients. Individuals who already work with a clinician in the NVOX Network can complete the NVOX assessment for $349, with their clinician receiving access to the case record and report.
- NVOX Direct: Qualified clinicians can also apply to receive NVOX Direct cases, with no cost to join the network. Clinicians are compensated for the professional services they provide. Individuals using NVOX Direct can access the $499 option, which includes the assessment, professional case review, a comprehensive report, and a professional feedback session.
How NVOX Works
The platform brings multiple layers of evidence into one structured, traceable case record, including clinical, developmental and functional information, collateral evidence when relevant, objective performance data from digital tasks, and supporting behavioral and analytical signals derived from video observation, movement, gaze and voice when data quality and assessment conditions support interpretation. AI-supported analysis organizes and synthesizes these evidence layers into a comprehensive clinical report for professional review. No single questionnaire, test, behavioral signal, or AI output independently determines the result.
Clinicians can review where sources converge or conflict, identify missing information, and consider quality and interpretive limitations. The result is not a single ADHD score, but a documented clinical picture of the person behind the assessment. Clinical interpretation remains in professional hands, and final report release is subject to licensed clinical review and authorization. More information is available in NVOX’s clinical design and evidence framework.
NVOX currently supports ADHD assessment across ages 8 through 57, with age-specific normative reference data incorporated into the assessment framework to support developmentally appropriate interpretation.
The company has also conducted an internal evidence program examining the platform and its assessment layers, with methodology, findings, and limitations documented in its evidence materials. NVOX does not present its internal evidence as a substitute for independent research and is preparing for external research and independent validation.
NVOX Network
NVOX is now inviting psychologists, psychiatrists and other qualified clinical professionals authorized to conduct ADHD assessments within their licensure and scope of practice to join the NVOX Network at no cost. Learn more about joining the NVOX Network.
About NVOX
NVOX Inc. provides a clinician-integrated, multimodal platform designed to make ADHD assessment more structured, accessible and efficient. The platform brings clinical history, collateral evidence, objective performance data and other assessment information into a structured case record for clinician review. NVOX organizes complex evidence, streamlines assessment workflows and produces comprehensive clinical reports while keeping clinical interpretation in professional hands and final report release subject to licensed clinical review and authorization. Learn more about the NVOX Network.
About NVOX Foundation
NVOX Foundation Inc. is a legally and operationally separate nonprofit focused on expanding access to professional ADHD assessment for individuals and families facing financial, geographic and other barriers. Learn more at nvox.org.
Media Contact
Guyer Group
Elyse Familant
nvox@guyergroup.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/nvox-launches-us-clinical-network-to-address-clinician-time-bottleneck-in-adhd-assessment-302857782.html
SOURCE NVOX
